Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899246 · ClinicalTrials.gov registry record · Phase 1
Sickle Cell Pain: Intervention With Capsaicin Exposure
A Phase 1 study, sponsored by Children's Hospital of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03899246 is a Phase 1 study that has completed, run by Children's Hospital of Michigan. The registered enrollment target is 10 participants.
The verdict
NCT03899246, a Phase 1 study, has completed, sponsored by Children's Hospital of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study evaluates the safety and feasibility of using high dose topical capsaicin patches for the treatment of neuropathic pain in pediatric patients with sickle cell disease, as well as the feasibility of using a number of tests for the evaluation and monitoring of neuropathic pain. The hypothesis, based on evidence obtained from studies in adults with neuropathic pain related to other diseases as well as a single previously published study of capsaicin in pediatric patients, is that capsaicin will be well tolerated in this population. Additionally, it is hypothesized that it is feasible to monitor changes in neuropathic pain via the testing listed below.
Interventions
- DRUG Eight Percent Topical Capsaicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-03 |
| Est. Completion | 2020-03-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03899246
The ClinicalTrials.gov registry entry for NCT03899246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Michigan, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eight Percent Topical Capsaicin is the first listed.
NCT03899246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03899246 about?
NCT03899246 is a clinical study titled "Sickle Cell Pain: Intervention With Capsaicin Exposure". This study evaluates the safety and feasibility of using high dose topical capsaicin patches for the treatment of neuropathic pain in pediatric patients with sickle cell disease, as well as the feasibility of using a number of tests for the evaluation and monitoring of neuropathic pain. The hypothes...
What is the current status of trial NCT03899246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-07-03. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03899246?
The interventions under investigation include: Eight Percent Topical Capsaicin (DRUG).
Who is sponsoring clinical trial NCT03899246?
This trial is sponsored by Children's Hospital of Michigan, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.